Edwards Reports Strong LifeStent Leg Artery Data, But PMA Will Wait Till ’08

Edwards Lifesciences reported positive clinical results for its LifeStent femoral/popliteal stent, but FDA is asking for more bench test data for the product's PMA for the femoral indication

More from Archive

More from Medtech Insight